Emerging Circulating Molecular Biomarkers: New Horizons in Lumbar Disc Herniation

Area of Science:

• Biomedical research
• Molecular biology
• Clinical diagnostics

Background:

• Disc herniation pathophysiology is complex.
• Biomarkers are crucial for understanding disease progression, treatment monitoring, and patient stratification.
• Current research focuses on molecular and cellular biomarkers.

Purpose of the Study:

• To review advances in identifying and validating biomarkers for disc herniation.
• To emphasize the potential of biomarkers in bridging basic science and clinical application.
• To highlight the role of inflammatory mediators, extracellular matrix turnover, and immune cell activity.

Main Methods:

• Review of current literature on biomarkers.
• Analysis of genomic, transcriptomic, proteomic, and metabolomic data.
• Focus on inflammatory and immune responses in disc herniation.

Main Results:

• Identification of emerging biomarkers across multiple 'omics' domains.
• Emphasis on the interplay of inflammation, ECM turnover, and immune cells.
• Challenges include standardization, comparability, and clinical implementation.

Conclusions:

• Biomarkers are vital for diagnosing and predicting lumbar disc herniation.
• Multi-omics integration and bioinformatics are key for future biomarker panels.
• Personalized medicine approaches are facilitated by advanced biomarker discovery.